Breaking News

SCM Gains MHRA Approval for Commercial Facility

To supply licensed commercial products and aid clinical projects

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

SCM Pharma’s new contract manufacturing facility in Northeast England has received approval for commercial production following a successful inspection from the Medicines and Healthcare products Regulatory Agency (MHRA). The company will use its new 26,000-sq.-ft. site for the supply of licensed commercial products and to complement its nearby clinical manufacturing facility for projects requiring scale-up.   The site’s capabilities include: highly potent, flammable and toxic products, along wit...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters